US 11779603
HERV-E reactive T cell receptors and methods of use
granted A61KA61K2239/56A61K40/11
Quick answer
US patent 11779603 (HERV-E reactive T cell receptors and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2239/56, A61K40/11, A61K40/32, A61K40/46